| 書目名稱 | Overcoming Breast Cancer Therapy Resistance | | 副標(biāo)題 | From Mechanisms to P | | 編輯 | Zodwa Dlamini | | 視頻video | http://file.papertrans.cn/706/705221/705221.mp4 | | 概述 | Provides current knowledge and understanding of the challenges associated with drug resistance in breast cancer.Discusses the latest advancements in therapeutic approaches for conquering drug resistan | | 圖書封面 |  | | 描述 | .This book addresses the pressing problem of drug resistance in the treatment of breast cancer. It provides a comprehensive understanding of the complex mechanisms underlying drug resistance and presents the latest advances in therapeutic approaches to overcome this enormous challenge...The book begins with an introduction to the biology of breast cancer, treatment modalities and the mechanisms of drug resistance. This includes the principles of drug resistance in targeted, immune-, endocrine and chemotherapy. In the following sections, the authors present innovative strategies to overcome drug resistance and new research directions, among others the role of the microbiome in drug resistance, molecular profiling of patients for personalized medical care, and new drug delivery systems. Finally, the book concludes with a discussion of the differences in the prevalence and treatment success of breast cancer between high- and low-income countries.? ..This book is an informative resource for students, researchers, and clinicians in the field of breast cancer research and oncology in general.. | | 出版日期 | Book 2024 | | 關(guān)鍵詞 | drug resistance; targeted therapy; immunotherapy; artificial intelligence; personalized medicine; chemoth | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-031-52860-6 | | isbn_softcover | 978-3-031-52862-0 | | isbn_ebook | 978-3-031-52860-6 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-9 00:29
發(fā)表于 2025-3-21 19:05:11
